Piątek Łukasz, Wilczek Krzysztof, Kurzawski Jacek, Gierlotka Marek, Gąsior Mariusz, Poloński Lech, Sadowski Marcin
The Faculty of Medicine and Health Sciences, Jan Kochanowski University, Department of Anatomy, Kielce, Poland.
2 Department of Cardiology, Świętokrzyskie Cardiology Centre, Kielce, Poland.
Arch Med Sci. 2020 Feb 28;16(4):781-788. doi: 10.5114/aoms.2018.76112. eCollection 2020.
Gender-related differences in the treatment of patients with non-ST elevation myocardial infarction (NSTEMI) have been reported in many previous studies despite the fact that an equal approach is recommended in all current guidelines. The aim of the study was to investigate whether gender-related discrepancies in the management of NSTEMI patients have changed.
Between 2012 and 2014 a total of 66,667 patients (38.3% of whom were women) with the final diagnosis of NSTEMI were included into the retrospective analysis of the Polish Registry of Acute Coronary Syndromes (PL-ACS). Differences in clinical profile, treatment, and outcomes were analysed.
Women were older than men and more often had comorbidities. They were less likely to undergo coronary angiography (88.4% vs. 92.1%, < 0.05) as well as percutaneous coronary intervention (59.6% vs. 71.9%, < 0.05). In the general population women had also significantly worse in-hospital prognosis as well as in 12-month follow-up. After the age adjustment the outcomes in women were at least as good as in men. In multivariate analysis females had the same risk as men in-hospital RR = 1.02 (95% CI: 0.97-1.08, = 0.45) and lower in 12-month observation RR = 0.94 (95% CI: 0.92-0.97, < 0.0001).
In comparison with previous reports on NSTEMI patients, gender-related disparities in the treatment and outcomes were radically reduced. Unadjusted mortality rates were still higher in women as a consequence of their older age. After the age adjustment, mortality ratios were similar in both genders. The long-term prognosis seems to be even better in women.
尽管当前所有指南都推荐采用平等的治疗方法,但此前许多研究都报道了非ST段抬高型心肌梗死(NSTEMI)患者治疗中存在性别差异。本研究的目的是调查NSTEMI患者管理中与性别相关的差异是否发生了变化。
在2012年至2014年期间,共有66667例最终诊断为NSTEMI的患者(其中38.3%为女性)被纳入波兰急性冠状动脉综合征注册研究(PL-ACS)的回顾性分析。分析了临床特征、治疗方法和治疗结果的差异。
女性患者年龄大于男性,且更常伴有合并症。她们接受冠状动脉造影的可能性较小(88.4%对92.1%,P<0.05),接受经皮冠状动脉介入治疗的可能性也较小(59.6%对71.9%,P<0.05)。在总体人群中,女性患者的住院预后以及12个月随访结果也明显更差。年龄调整后,女性患者的治疗结果至少与男性一样好。在多变量分析中,女性患者住院期间的风险与男性相同(相对风险RR=1.02,95%置信区间:0.97-1.08,P=0.45),而在12个月观察期内风险较低(RR=0.94,95%置信区间:0.92-0.97,P<0.0001)。
与之前关于NSTEMI患者的报道相比,治疗和治疗结果方面与性别相关的差异已大幅减少。由于女性年龄较大,未经调整的死亡率仍然较高。年龄调整后,两性的死亡率相似。女性的长期预后似乎更好。